Neoantigen quality predicts immunoediting in survivors of pancreatic cancer

Cancer immunoediting 1 is a hallmark of cancer 2 that predicts that lymphocytes kill more immunogenic cancer cells to cause less immunogenic clones to dominate a population. Although proven in mice 1 , 3 , whether immunoediting occurs naturally in human cancers remains unclear. Here, to address this...

Full description

Saved in:

Bibliographic Details
Published in:	Nature (London) Vol. 606; no. 7913; pp. 389 - 395
Main Authors:	Łuksza, Marta, Sethna, Zachary M., Rojas, Luis A., Lihm, Jayon, Bravi, Barbara, Elhanati, Yuval, Soares, Kevin, Amisaki, Masataka, Dobrin, Anton, Hoyos, David, Guasp, Pablo, Zebboudj, Abderezak, Yu, Rebecca, Chandra, Adrienne Kaya, Waters, Theresa, Odgerel, Zagaa, Leung, Joanne, Kappagantula, Rajya, Makohon-Moore, Alvin, Johns, Amber, Gill, Anthony, Gigoux, Mathieu, Wolchok, Jedd, Merghoub, Taha, Sadelain, Michel, Patterson, Erin, Monasson, Remi, Mora, Thierry, Walczak, Aleksandra M., Cocco, Simona, Iacobuzio-Donahue, Christine, Greenbaum, Benjamin D., Balachandran, Vinod P.
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 09.06.2022 Nature Publishing Group
Subjects:	631/57/2266 631/67/580/1884 631/67/69 Antigens Cancer Cloning Discrimination Evolution Humanities and Social Sciences Hypotheses Immune system Immunogenicity Life Sciences Lymphocytes Lymphocytes T Major histocompatibility complex multidisciplinary Mutation Neoantigens Pancreatic cancer Peptides Physics Science Science (multidisciplinary) Survival T cell receptors Thymus gland Tumors
ISSN:	0028-0836, 1476-4687, 1476-4687
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!